LLY
Eli Lilly and Company
NYSE · USHealthcareDrug Manufacturers - General
$1146.85-2.74%
Price as of Jul 20, 2026
LLY capital
Eli Lilly and Company capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 1.39x
- Net debt / equity
- 1.23x
- Debt / assets
- 0.37x
- Debt / EBITDA
- 1.30x
- Net debt / EBITDA
- 1.14x
Liquidity & coverage
- Current ratio
- 1.50x
- Quick ratio
- 1.10x
- Cash ratio
- 0.14x
- Interest coverage
- 37.50x
- EBITDA / interest
- 37.87x
- Working capital
- $18.2B
Cash & dividend
- FCF / debt
- 0.31x
- Cash flow / debt
- 0.47x
- Dividend per share
- $6.46
- Dividend yield
- 0.6%
- Dividend growth 1y
- +15.4%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.